Literature DB >> 23424333

I.m.I.d. Spurs innovations, tough payer questions.

Jill Marquardt.   

Abstract

New understanding of immunodeficiencies has yielded effective biologic therapies. The utility of these therapies changes the face of formulary decision making.

Entities:  

Year:  2006        PMID： 23424333      PMCID： PMC3571043     

Source DB:  PubMed          Journal:  Biotechnol Healthc        ISSN： 1554-169X


  3 in total

1.  A nursing process model: quantifying infusion therapy resource consumption.

Authors:  Christine A Pierce; Judith J Baker
Journal:  J Infus Nurs       Date:  2004 Jul-Aug

2.  Treatment compliance and dosage administration among rheumatoid arthritis patients receiving infliximab, etanercept, or methotrexate.

Authors:  Carolyn R Harley; Jennifer R Frytak; Neeta Tandon
Journal:  Am J Manag Care       Date:  2003-10       Impact factor: 2.229

Review 3.  Defining and characterizing the late-stage biopharmaceutical pipeline.

Authors:  Paul C Nagle; Timothy F Lugo; Christopher A Nicita
Journal:  Am J Manag Care       Date:  2003-10       Impact factor: 2.229
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.